HK1135110A1 - Nk1 receptor antagonist composition nk1 - Google Patents
Nk1 receptor antagonist composition nk1Info
- Publication number
- HK1135110A1 HK1135110A1 HK10103110.7A HK10103110A HK1135110A1 HK 1135110 A1 HK1135110 A1 HK 1135110A1 HK 10103110 A HK10103110 A HK 10103110A HK 1135110 A1 HK1135110 A1 HK 1135110A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- receptor antagonist
- antagonist composition
- composition
- receptor
- antagonist
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q7/00—Preparations for affecting hair growth
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Dermatology (AREA)
- Pulmonology (AREA)
- Epidemiology (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Nutrition Science (AREA)
- Pain & Pain Management (AREA)
- Urology & Nephrology (AREA)
- Molecular Biology (AREA)
- Psychiatry (AREA)
- Immunology (AREA)
- Otolaryngology (AREA)
- Mycology (AREA)
- Rheumatology (AREA)
- Addiction (AREA)
- Birds (AREA)
- Psychology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Anesthesiology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Ophthalmology & Optometry (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2006281907 | 2006-10-16 | ||
PCT/JP2007/069959 WO2008047709A1 (en) | 2006-10-16 | 2007-10-12 | Nk1 receptor antagonist composition |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1135110A1 true HK1135110A1 (en) | 2010-05-28 |
Family
ID=39313940
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK10103110.7A HK1135110A1 (en) | 2006-10-16 | 2010-03-25 | Nk1 receptor antagonist composition nk1 |
Country Status (8)
Country | Link |
---|---|
US (1) | US8426386B2 (xx) |
EP (1) | EP2075252B1 (xx) |
JP (1) | JP5204657B2 (xx) |
KR (1) | KR20090071581A (xx) |
CN (1) | CN101600724B (xx) |
HK (1) | HK1135110A1 (xx) |
MY (1) | MY177591A (xx) |
WO (1) | WO2008047709A1 (xx) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP5465444B2 (ja) * | 2008-02-18 | 2014-04-09 | ライオン株式会社 | 痒み抑制剤および痒み抑制組成物 |
US20120077803A1 (en) * | 2009-02-24 | 2012-03-29 | Novartis Ag | Uses Of NK Receptor Antagonists |
JP5650949B2 (ja) * | 2009-08-13 | 2015-01-07 | ライオン株式会社 | 洗浄剤組成物 |
WO2011027721A1 (ja) * | 2009-09-02 | 2011-03-10 | ライオン株式会社 | 洗浄剤組成物 |
JP5558332B2 (ja) * | 2009-12-21 | 2014-07-23 | ライオン株式会社 | 頭皮頭髪化粧料 |
JP5628574B2 (ja) * | 2009-12-28 | 2014-11-19 | ライオン株式会社 | 化粧料組成物 |
JP2023049461A (ja) * | 2021-09-29 | 2023-04-10 | ライオン株式会社 | 液体皮膚外用組成物 |
Family Cites Families (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2678605B2 (ja) * | 1987-10-30 | 1997-11-17 | 日本食品化工株式会社 | 腸内細菌叢改善剤 |
JPH02229103A (ja) | 1989-02-28 | 1990-09-11 | Sanko Seibutsu Kagaku Kenkyusho:Kk | 皮膚化粧料 |
JPH04360820A (ja) * | 1991-06-04 | 1992-12-14 | Pola Chem Ind Inc | 化粧料 |
JPH05294837A (ja) * | 1992-04-17 | 1993-11-09 | Kao Corp | 皮脂分泌促進剤 |
JPH06219935A (ja) * | 1993-01-25 | 1994-08-09 | Kanebo Ltd | 皮膚化粧料 |
FR2719474B1 (fr) | 1994-05-05 | 1996-05-31 | Oreal | Utilisation d'un antagoniste de substance P dans une composition cosmétique et composition obtenue. |
US6203803B1 (en) | 1994-12-14 | 2001-03-20 | Societe L'oreal S.A. | Use of a substance P antagonist in a cosmetic composition, and the composition thus obtained |
FR2728265A1 (fr) | 1994-12-19 | 1996-06-21 | Oreal | Utilisation d'un antagoniste de substance p dans une composition pharmaceutique |
FR2728169A1 (fr) | 1994-12-19 | 1996-06-21 | Oreal | Utilisation d'un antagoniste de substance p pour le traitement des prurits et des dysesthesies oculaires ou palpebrales |
FR2728165A1 (fr) | 1994-12-19 | 1996-06-21 | Oreal | Utilisation d'un antagoniste de substance p pour le traitement des rougeurs cutanees d'origine neurogene |
FR2728166A1 (fr) | 1994-12-19 | 1996-06-21 | Oreal | Composition topique contenant un antagoniste de substance p |
JPH08217695A (ja) * | 1995-02-10 | 1996-08-27 | Pola Chem Ind Inc | 皮膚外用剤 |
US5972905A (en) | 1995-06-14 | 1999-10-26 | Institute Of Immunology Co., Ltd. | Use of oligosaccharides for the treatment of pruritus cutaneus associated with renal failure |
GB9700597D0 (en) | 1997-01-14 | 1997-03-05 | Sandoz Pharma Uk | Organic compounds |
EP0887070B1 (en) * | 1997-05-30 | 2004-12-22 | Kibun Food ChemiFA Co., Ltd. | External composition for skin comprising sphingoglycolipid |
AU752880B2 (en) | 1998-07-27 | 2002-10-03 | E-L Management Corporation | Topical compositions containing sialyl sugars and their derivatives |
JP4388175B2 (ja) | 1999-09-10 | 2009-12-24 | 明治乳業株式会社 | 非特異的IgE産生促進剤 |
JP2001213772A (ja) | 2000-01-28 | 2001-08-07 | Health Science Center:Kk | 皮膚塗布剤組成物 |
JP2002308783A (ja) * | 2001-04-13 | 2002-10-23 | Geo Co Ltd | 皮膚または粘膜疾患予防、治療用医薬組成物 |
JP2003012501A (ja) * | 2001-06-27 | 2003-01-15 | Rohto Pharmaceut Co Ltd | 鎮痒エアゾール製剤 |
JP2003113019A (ja) | 2001-09-28 | 2003-04-18 | Lion Corp | 皮膚外用剤 |
AUPS052802A0 (en) * | 2002-02-15 | 2002-03-07 | Praxis Pharmaceuticals International Pty Ltd | Carbohydrate-based anti-wrinkle and tissue remodelling compounds |
JP2004161718A (ja) | 2002-11-15 | 2004-06-10 | Nippon Zoki Pharmaceut Co Ltd | タキキニン拮抗剤 |
JP4360820B2 (ja) | 2003-03-28 | 2009-11-11 | 日本たばこ産業株式会社 | 自動販売機の商品払出装置 |
-
2007
- 2007-10-12 CN CN2007800384688A patent/CN101600724B/zh active Active
- 2007-10-12 EP EP07829695.1A patent/EP2075252B1/en not_active Not-in-force
- 2007-10-12 JP JP2008539786A patent/JP5204657B2/ja active Active
- 2007-10-12 KR KR1020097006777A patent/KR20090071581A/ko active Search and Examination
- 2007-10-12 WO PCT/JP2007/069959 patent/WO2008047709A1/ja active Application Filing
- 2007-10-12 MY MYPI20091528A patent/MY177591A/en unknown
- 2007-10-12 US US12/445,811 patent/US8426386B2/en active Active
-
2010
- 2010-03-25 HK HK10103110.7A patent/HK1135110A1/xx unknown
Also Published As
Publication number | Publication date |
---|---|
JPWO2008047709A1 (ja) | 2010-02-25 |
KR20090071581A (ko) | 2009-07-01 |
CN101600724A (zh) | 2009-12-09 |
MY177591A (en) | 2020-09-22 |
EP2075252B1 (en) | 2015-07-29 |
US20110039801A1 (en) | 2011-02-17 |
CN101600724B (zh) | 2013-03-13 |
US8426386B2 (en) | 2013-04-23 |
EP2075252A1 (en) | 2009-07-01 |
EP2075252A4 (en) | 2010-05-26 |
WO2008047709A1 (en) | 2008-04-24 |
JP5204657B2 (ja) | 2013-06-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2058304A4 (en) | P2X4 RECEPTOR ANTAGONIST | |
HRP20151108T1 (xx) | Antagonisti nogo-receptora | |
EP2099454A4 (en) | AMINOPYRROLIDINES AS CHEMOKINE RECEPTOR ANTAGONISTS | |
HK1136302A1 (en) | Progesterone receptor antagonists | |
EP2184278A4 (en) | P2X4 RECEIVER ANTAGONIST | |
EP2034832A4 (en) | IL-8 RECEPTOR ANTAGONIST | |
IL196587A0 (en) | 2-phenyl-indoles as prostaglandin d2 receptor antagonists | |
EP1935874A4 (en) | ANTAGONIST OF THE RECEIVER OF S1P3 | |
EP2191830A4 (en) | SOLID PREPARATION COMPRISING A NPYY5 RECEPTOR ANTAGONIST | |
IL195807A0 (en) | Cgrp receptor antagonists | |
IL198542A0 (en) | 2-aminoquinolines as 5-ht(5a)receptor antagonists | |
HK1135110A1 (en) | Nk1 receptor antagonist composition nk1 | |
IL192693A0 (en) | Urotensin ii receptor antagonists | |
ZA200808766B (en) | Nitrated heterocyclic compounds as endothelin receptor antagonist | |
IL205949A0 (en) | 3-carboxypropyl-aminotetralin derivatives and related compounds as mu opioid receptor antagonists | |
HK1137353A1 (en) | Urotensin ii receptor antagonists ii | |
EP2120564A4 (en) | BENZAZEPINE COMPOUNDS AS CGRP RECEPTOR ANTAGONISTS | |
ZA200903496B (en) | Spiro-piperidine derivatives as via receptor antagonists | |
ZA200903523B (en) | Poly-TLR antagonist | |
IL193427A0 (en) | Polypeptide antagonist | |
IL193294A0 (en) | Piperidine derivatives as cxcr3 receptor antagonists | |
GB0525029D0 (en) | Receptor Antagonist | |
ZA200810564B (en) | 2-phenyl-indoles as prostaglandin D2 receptor antagonists | |
IL193295A0 (en) | Piperidine derivatives as cxcr3 receptor antagonists | |
GB0701632D0 (en) | MET receptor antagonists |